Drug Shortage Report for DEXTROSE INJECTION
| Report ID | 223983 |
| Drug Identification Number | 02517132 |
| Brand name | DEXTROSE INJECTION |
| Common or Proper name | DEXTROSE INJECTION |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE |
| Strength(s) | 50% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10 x 50mL vial / fiole |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2024-04-01 |
| Actual start date | 2024-04-01 |
| Estimated end date | 2024-05-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-02 |
| Company comments | Omega has made the decision to re-instate an allocation for Omega Dextrose to prevent overstocking of the Canadian labeled product. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-04-02 | English | Compare |
| v4 | 2024-03-31 | French | Compare |
| v3 | 2024-03-31 | English | Compare |
| v2 | 2024-03-31 | French | Compare |
| v1 | 2024-03-30 | English | Compare |
Showing 1 to 5 of 5